Company Profile
Updated: 03-NOV-09Biovet AD
International Public Subsidiary
ul Petar Rakov No. 39, Peshtera, 4550, Bulgaria
()359 0350 656 19, 359 0350 656 36 fax, http://www.biovet.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture and marketing of medicated and nutritional feed additives, enzymes, bulk active substances and pharmceuticals for animal health and productivity; intermediates, active ingredients and medicines for the human pharmaceuticals industry
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Karoll - Bulgarian Daily Newsletter - Oct 12, 2009.
Bulgarian Banks and Brokers Reports; 10/13/2009; 1596 words; ...Change Insurance Company Euro Ins AD 5IC + 4.44% Eurohold Bulgaria...CB Central Cooperative Bank AD 4CF + 2.68% Top Losers Ticker Change Biovet JSC-Peshtera 53B -9.94...Blagoevgrad 55B -6.98% Toplivo AD 3TV -4.29% * Gainers are...
Biovet AD (Bulgaria) GMP Certified By the Bulgarian Institute for Control of Veterinary Medicinal Products Can Be Viewed Inside This Latest Company Profile.
M2 Presswire; 5/27/2009; 714 words; ...May 2009-Research and Markets: Biovet AD (Bulgaria) GMP Certified By the...researchandmarkets.com/research/8990b0/biovet_ad_bulgari) has announced the addition of the "Biovet AD (Bulgaria) - Company Profile...
Examine the Veterinary Health Markets.
Business Wire; 12/11/2008; 3759 words; ...Health - Biobest Laboratories - BioVet, Inc. - Boehringer Ingelheim...Biosystems, Inc. - Momina krepost AD Veliko Tarnovo - Monsanto - Mosaic...VCA Antech, Inc. - Velefarm ad Beograd - Veterinarski Zavod Subotica ad Subotica - Vetoquinol - Virbac...
Understand the Bulgarian Pharmaceutical Market.
Business Wire; 12/4/2006; 540 words; ...Actavis, Adipharm, Biopharm Engineering, Biovet, Bul Bio, Bulgarian Rose Sevtopolis...Roche Bulgaria, Sanita Trading, Sofia AD, Sofstroy, Sopharma, Tchaikapharma...Companies Mentioned: * Actavis * Sopharma * Biovet For more information visit http://www...
Forbes Medi-Tech Inc. Reports Fourth Quarter and Year-end Results For the Fiscal Year Ended July 31, 2000.
Canadian Corporate News; 5/2/2001; 2229 words; ...VP4, continued upscaling activities at Biovet JSV in Bulgaria for fermentation and subsequent production of Androstenedione (AD), and Phytrol(TM) pilot production...Representative Agreements for Androstenedione (AD) and Androstadienedione (ADD) paving...
Recent News Articles
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning